VYNE icon

VYNE Therapeutics

104 hedge funds and large institutions have $138M invested in VYNE Therapeutics in 2020 Q4 according to their latest regulatory filings, with 18 funds opening new positions, 37 increasing their positions, 23 reducing their positions, and 19 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
104
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
2
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
Puts
Net Calls
Net Calls Change

Top Buyers

1 +$3.39M
2 +$3.31M
3 +$946K
4
Squarepoint
Squarepoint
New York
+$791K
5
State Street
State Street
Massachusetts
+$783K

Top Sellers

1 -$1.39M
2 -$581K
3 -$352K
4
Morgan Stanley
Morgan Stanley
New York
-$251K
5
SSA
Schonfeld Strategic Advisors
New York
-$233K
Name Holding Trade Value Shares
Change
Change in
Stake
26
$571K
27
$565K
28
$552K
29
$471K
30
$467K
31
$427K
32
$411K
33
$347K
34
$322K
35
$303K
36
$294K
37
$289K
38
$286K
39
$278K
40
$256K
41
$236K
42
$205K
43
$200K
44
$183K
45
$179K
46
$163K
47
$154K
48
$153K
49
$147K
50
$133K